Competitive RisksA combination of more competition, slowing decision-making and existing customers shifting to Augmedix's lower cost offerings is behind the company lowering its 2024 revenue guidance.
Customer ShiftLive customers can give a 90-day notification to switch to the lower-cost Augmedix Go Assist, expecting a bigger drop in revenue in 2H24.
Revenue GuidanceManagement lowered 2024 revenue guidance to $52.0M-$55.0M, from $60.0M-$62.0M, up 19.3% at the midpoint.